{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:30Z","timestamp":1792525230293,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Natural Science Foundation","award":["CSTB2022NSCQ-MSX0165"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0165"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-02052-2","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:49:09Z","timestamp":1790826549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy"],"prefix":"10.1007","volume":"26","author":[{"given":"Youmin","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2052_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","volume":"3","author":"J Bartek","year":"2003","unstructured":"Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421\u2013429","journal-title":"Cancer Cell"},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1101\/gad.14.3.278","volume":"14","author":"NH Chehab","year":"2000","unstructured":"Chehab NH, Malikzay A, Appel M, Halazonetis TD (2000) Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 14:278\u2013288","journal-title":"Genes Dev"},{"key":"2052_CR5","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.7150\/ijms.49690","volume":"17","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou Q, Liu C, Zeng Y, Yuan S (2020) Klotho deficiency aggravates diabetes-induced podocyte injury due to DNA damage caused by mitochondrial dysfunction. Int J Med Sci 17:2763\u20132772","journal-title":"Int J Med Sci"},{"key":"2052_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40001-023-01054-1","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lin L, Rao S, Tao X, Cui J, Wan J (2023) Complement C3 mediates podocyte injury through TLR4\/NF\u039aB-P65 signaling during ischemia-reperfusion acute kidney injury and post-injury fibrosis. Eur J Med Res 28:135","journal-title":"Eur J Med Res"},{"key":"2052_CR3","doi-asserted-by":"publisher","first-page":"1581691","DOI":"10.3389\/fendo.2025.1581691","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Du P, Jiang T, Li Y, Li Y, Liu Y, Yang B, Kang J, Duan J, Ma Y, Chen X, Jiang H (2025) Identification of potential biomarkers for diabetic nephropathy via UPLC-MS\/MS-based metabolomics. Front Endocrinol (Lausanne) 16:1581691","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"672350","DOI":"10.3389\/fendo.2021.672350","volume":"12","author":"Y Deng","year":"2021","unstructured":"Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, Deng X, Xiang D, Zhu Y, Xu P, Zhai Z, Zhang D, Dai Z, Gao J (2021) Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019. Front Endocrinol (Lausanne) 12:672350","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2052_CR7","doi-asserted-by":"publisher","first-page":"2365408","DOI":"10.1080\/0886022X.2024.2365408","volume":"46","author":"J Feng","year":"2024","unstructured":"Feng J, Xie L, Lu W, Yu X, Dong H, Ma Y, Kong R (2024) Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1\/CDK1\/cyclin B1 axis. Ren Fail 46:2365408","journal-title":"Ren Fail"},{"key":"2052_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1681\/ASN.2018090896","volume":"30","author":"J Fu","year":"2019","unstructured":"Fu J, Akat KM, Sun Z, Zhang W, Schlondorff D, Liu Z, Tuschl T, Lee K, He JC (2019) Single-Cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease. J Am Soc Nephrol 30:533\u2013545","journal-title":"J Am Soc Nephrol"},{"key":"2052_CR9","doi-asserted-by":"crossref","unstructured":"Giannou P, Gakiopoulou H, Stambolliu E, Petras D, Chalkia A, Kapota A, Palamaris K, Hadziyannis E, Thomas K, Alexakou Z, Bora M, Mintzias T, Vassilopoulos D, Patsouris E, Deutsch M (2024) Urine nephrin and podocalyxin reflecting podocyte damage and severity of kidney disease in various glomerular diseases-a cross-sectional study. J Clin Med 13","DOI":"10.20944\/preprints202405.0073.v1"},{"key":"2052_CR10","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F (2023) Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci 24","DOI":"10.3390\/ijms24119352"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"F313","DOI":"10.1152\/ajprenal.00328.2023","volume":"326","author":"NA Gujarati","year":"2024","unstructured":"Gujarati NA, Chow AK, Mallipattu SK (2024) Central role of podocytes in mediating cellular cross talk in glomerular health and disease. Am J Physiol Ren Physiol 326:F313\u2013f25","journal-title":"Am J Physiol Ren Physiol"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682\u2013690","journal-title":"Nat Chem Biol"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"e93182","DOI":"10.1371\/journal.pone.0093182","volume":"9","author":"Z Jia","year":"2014","unstructured":"Jia Z, Sun Y, Liu S, Liu Y, Yang T (2014) COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes. PLoS ONE 9:e93182","journal-title":"PLoS ONE"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejphar.2016.11.037","volume":"794","author":"Y Jin","year":"2017","unstructured":"Jin Y, Liu S, Ma Q, Xiao D, Chen L (2017) Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol 794:106\u2013114","journal-title":"Eur J Pharmacol"},{"key":"2052_CR15","doi-asserted-by":"publisher","first-page":"1271042","DOI":"10.3389\/fnetp.2023.1271042","volume":"3","author":"D Kaiser-Graf","year":"2023","unstructured":"Kaiser-Graf D, Schulz A, Mangelsen E, Rothe M, Bolbrinker J, Kreutz R (2023) Tissue lipidomic profiling supports a mechanistic role of the prostaglandin E2 pathway for albuminuria development in glomerular hyperfiltration. Front Netw Physiol 3:1271042","journal-title":"Front Netw Physiol"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"F1054","DOI":"10.1152\/ajprenal.00103.2020","volume":"319","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Kim SH, Kim M, Baik H, Park SJ, Kang MS, Kim DH, Kim BW, Markowitz SD, Bae KB (2020) Inhibition of 15-PGDH prevents ischemic renal injury by the PGE(2)\/EP(4) signaling pathway mediating vasodilation, increased renal blood flow, and increased adenosine\/A(2A) receptors. Am J Physiol Ren Physiol 319:F1054\u2013f66","journal-title":"Am J Physiol Ren Physiol"},{"key":"2052_CR17","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/ndt\/gfad052","volume":"38","author":"W Kriz","year":"2023","unstructured":"Kriz W, L\u00f6wen J, Gr\u00f6ne HJ (2023) The complex pathology of diabetic nephropathy in humans. Nephrol Dial Transpl 38:2109\u20132119","journal-title":"Nephrol Dial Transpl"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fendo.2014.00160","volume":"5","author":"R Lennon","year":"2014","unstructured":"Lennon R, Randles MJ, Humphries MJ (2014) The importance of podocyte adhesion for a healthy glomerulus. Front Endocrinol (Lausanne) 5:160","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2052_CR19","doi-asserted-by":"publisher","first-page":"e0328352","DOI":"10.1371\/journal.pone.0328352","volume":"20","author":"H Li","year":"2025","unstructured":"Li H, Li Q, Fan Z, Shen Y, Li J, Zhang F (2025) Identification of podocyte molecular markers in diabetic kidney disease via single-cell RNA sequencing and machine learning. PLoS ONE 20:e0328352","journal-title":"PLoS ONE"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"798316","DOI":"10.3389\/fcell.2022.798316","volume":"10","author":"X Lu","year":"2022","unstructured":"Lu X, Li L, Suo L, Huang P, Wang H, Han S, Cao M (2022) Single-Cell RNA Sequencing Profiles Identify Important Pathophysiologic Factors in the Progression of Diabetic Nephropathy. Front Cell Dev Biol 10:798316","journal-title":"Front Cell Dev Biol"},{"key":"2052_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1080\/0886022X.2022.2079525","volume":"44","author":"Z Ma","year":"2022","unstructured":"Ma Z, Zhu L, Wang S, Guo X, Sun B, Wang Q, Chen L (2022) Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome. Ren Fail 44:923\u2013932","journal-title":"Ren Fail"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"e1011375","DOI":"10.1371\/journal.pgen.1011375","volume":"20","author":"CE McCarthy-Leo","year":"2024","unstructured":"McCarthy-Leo CE, Brush GS, Pique-Regi R, Luca F, Tainsky MA, Finley RL Jr. (2024) Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2. PLoS Genet 20:e1011375","journal-title":"PLoS Genet"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fphys.2020.00138","volume":"11","author":"S Miao","year":"2020","unstructured":"Miao S, Lv C, Liu Y, Zhao J, Li T, Wang C, Xu Y, Wang X, Xiao X, Zhang H (2020) Pharmacologic Blockade of 15-PGDH Protects Against Acute Renal Injury Induced by LPS in Mice. Front Physiol 11:138","journal-title":"Front Physiol"},{"key":"2052_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2015.04.017","volume":"760","author":"WJ Ni","year":"2015","unstructured":"Ni WJ, Ding HH, Tang LQ (2015) Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. Eur J Pharmacol 760:103\u2013112","journal-title":"Eur J Pharmacol"},{"key":"2052_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","volume":"34","author":"R N\u00f8rregaard","year":"2015","unstructured":"N\u00f8rregaard R, Kwon TH, Fr\u00f8ki\u00e6r J (2015) Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney. Kidney Res Clin Pract 34:194\u2013200","journal-title":"Kidney Res Clin Pract"},{"key":"2052_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1139\/bcb-2022-0008","volume":"101","author":"N Qasim","year":"2023","unstructured":"Qasim N, Arif A, Mahmood R (2023) Hyperglycemia enhances the generation of ROS and RNS that impair antioxidant power and cause oxidative damage in human erythrocytes. Biochem Cell Biol 101:64\u201376","journal-title":"Biochem Cell Biol"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/bph.14935","volume":"177","author":"X Qin","year":"2020","unstructured":"Qin X, Jiang M, Zhao Y, Gong J, Su H, Yuan F, Fang K, Yuan X, Yu X, Dong H, Lu F (2020) Berberine protects against diabetic kidney disease via promoting PGC-1\u03b1-regulated mitochondrial energy homeostasis. Br J Pharmacol 177:3646\u20133661","journal-title":"Br J Pharmacol"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","volume":"124","author":"K Reidy","year":"2014","unstructured":"Reidy K, Kang HM, Hostetter T, Susztak K (2014) Molecular mechanisms of diabetic kidney disease. J Clin Invest 124:2333\u20132340","journal-title":"J Clin Invest"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/ng1592","volume":"37","author":"J Reiser","year":"2005","unstructured":"Reiser J, Polu KR, M\u00f6ller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739\u2013744","journal-title":"Nat Genet"},{"key":"2052_CR30","doi-asserted-by":"publisher","first-page":"1497449","DOI":"10.1155\/2021\/1497449","volume":"2021","author":"N Samsu","year":"2021","unstructured":"Samsu N (2021) Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int 2021:1497449","journal-title":"Biomed Res Int"},{"key":"2052_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/13813455.2024.2392298","volume":"131","author":"C Shih-Wei","year":"2025","unstructured":"Shih-Wei C, Chen B, Mao Y, Xu Q, Chen Y (2025) Polygala fallax Hemsl. ameliorated high glucose-induced podocyte injury by modulating mitochondrial mPTP opening through the SIRT1\/PGC-1\u03b1 pathway. Arch Physiol Biochem 131:135\u2013146","journal-title":"Arch Physiol Biochem"},{"key":"2052_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/HEP.0000000000000437","volume":"79","author":"L Shu","year":"2024","unstructured":"Shu L, Li X, Liu Z, Li K, Shi A, Tang Y, Zhao L, Huang L, Zhang Z, Zhang D, Huang S, Lian S, Sheng G, Yan Z, Zhang Z, Xu Y (2024) Bile exosomal miR-182\/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Hepatology 79:307\u2013322","journal-title":"Hepatology"},{"key":"2052_CR33","doi-asserted-by":"crossref","unstructured":"Sinha SK, Nicholas SB (2023) Pathomechanisms of diabetic kidney disease. J Clin Med 12","DOI":"10.3390\/jcm12237349"},{"key":"2052_CR34","doi-asserted-by":"publisher","first-page":"121661","DOI":"10.1016\/j.lfs.2023.121661","volume":"322","author":"S Su","year":"2023","unstructured":"Su S, Ma Z, Wu H, Xu Z, Yi H (2023) Oxidative stress as a culprit in diabetic kidney disease. Life Sci 322:121661","journal-title":"Life Sci"},{"key":"2052_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","volume":"55","author":"K Susztak","year":"2006","unstructured":"Susztak K, Raff AC, Schiffer M, B\u00f6ttinger EP (2006) Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55:225\u2013233","journal-title":"Diabetes"},{"key":"2052_CR37","doi-asserted-by":"crossref","unstructured":"Tai HH, Ensor CM, Tong M, Zhou H, Yan F (2002) Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 68\u201369:483\u201393","DOI":"10.1016\/S0090-6980(02)00050-3"},{"key":"2052_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2174\/138161206776055958","volume":"12","author":"HH Tai","year":"2006","unstructured":"Tai HH, Cho H, Tong M, Ding Y (2006) NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des 12:955\u2013962","journal-title":"Curr Pharm Des"},{"key":"2052_CR38","doi-asserted-by":"publisher","first-page":"20693","DOI":"10.1074\/jbc.274.29.20693","volume":"274","author":"M Tamura","year":"1999","unstructured":"Tamura M, Gu J, Danen EH, Takino T, Miyamoto S, Yamada KM (1999) PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase\/Akt cell survival pathway. J Biol Chem 274:20693\u201320703","journal-title":"J Biol Chem"},{"key":"2052_CR39","doi-asserted-by":"publisher","first-page":"e2308556","DOI":"10.1002\/advs.202308556","volume":"11","author":"G Wang","year":"2024","unstructured":"Wang G, Wu H, Zhai X, Zhang L, Zhang C, Cheng C, Xu X, Gao E, Xiong X, Zhang J, Liu Z (2024) Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development. Adv Sci (Weinh) 11:e2308556","journal-title":"Adv Sci (Weinh)"},{"key":"2052_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.prostaglandins.2017.11.002","volume":"134","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Yamaguchi T, Ishihara N, Nakamura S, Tanaka S, Oka R, Imamura H, Sato Y, Ban N, Kawana H, Ohira M, Shimizu N, Saiki A, Tatsuno I (2018) 7-Ketocholesterol induces ROS-mediated mRNA expression of 12-lipoxygenase, cyclooxygenase-2 and pro-inflammatory cytokines in human mesangial cells: Potential role in diabetic nephropathy. Prostaglandins Other Lipid Mediat 134:16\u201323","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2052_CR41","doi-asserted-by":"publisher","first-page":"19619","DOI":"10.1073\/pnas.1908706116","volume":"116","author":"PC Wilson","year":"2019","unstructured":"Wilson PC, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke HG, Welling PA, Waikar SS, Humphreys BD (2019) The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A 116:19619\u201319625","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2052_CR42","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626\u20131634","journal-title":"Diabetes"},{"key":"2052_CR43","first-page":"555","volume":"41","author":"F Wu","year":"2018","unstructured":"Wu F, Yao DS, Lan TY, Wang C, Gao JD, He LQ, Huang D (2018) Berberine prevents the apoptosis of mouse podocytes induced by TRAF5 overexpression by suppressing NF-\u03baB activation. Int J Mol Med 41:555\u2013563","journal-title":"Int J Mol Med"},{"key":"2052_CR44","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s41440-023-01169-2","volume":"46","author":"N Yoshimoto","year":"2023","unstructured":"Yoshimoto N, Hayashi K, Hishikawa A, Hashiguchi A, Nakamichi R, Sugita-Nishimura E, Yoshida-Hama E, Azegami T, Nakayama T, Itoh H (2023) Significance of podocyte DNA damage and glomerular DNA methylation in CKD patients with proteinuria. Hypertens Res 46:1000\u20131008","journal-title":"Hypertens Res"},{"key":"2052_CR45","doi-asserted-by":"publisher","first-page":"8140479","DOI":"10.1155\/mi\/8140479","volume":"2025","author":"S Yu","year":"2025","unstructured":"Yu S, Han Z, Li C, Lu X, Li Y, Yuan X, Guo D (2025) Cross Talk Between Macrophages and Podocytes in Diabetic Nephropathy: Potential Mechanisms and Novel Therapeutics. Mediators Inflamm 2025:8140479","journal-title":"Mediators Inflamm"},{"key":"2052_CR46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/jmcb\/mju045","volume":"6","author":"L Zannini","year":"2014","unstructured":"Zannini L, Delia D, Buscemi G (2014) CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol 6:442\u2013457","journal-title":"J Mol Cell Biol"},{"key":"2052_CR50","doi-asserted-by":"publisher","first-page":"aaa2340","DOI":"10.1126\/science.aaa2340","volume":"348","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen WD, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai HH, Gerson SL, Ready JM, Posner B, Willson JK, Markowitz SD (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348:aaa2340","journal-title":"Science"},{"key":"2052_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1631\/jzus.B2300182","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang H, Wang X, Hu B, Li P, Abuduaini Y, Zhao H, Jieensihan A, Chen X, Wang S, Guo N, Yuan J, Li Y, Li L, Yang Y, Liu Z, Tang Z, Wang H (2024a) Human umbilical cord mesenchymal stem cells attenuate diabetic nephropathy through the IGF1R-CHK2-p53 signalling axis in male rats with type 2 diabetes mellitus. J Zhejiang Univ Sci B 25:568\u2013580","journal-title":"J Zhejiang Univ Sci B"},{"key":"2052_CR49","doi-asserted-by":"publisher","first-page":"1368481","DOI":"10.3389\/fendo.2024.1368481","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang J, Ren Y, Sun R, Zhai X (2024b) Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases. Front Endocrinol (Lausanne) 15:1368481","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2052_CR47","doi-asserted-by":"publisher","first-page":"20251146","DOI":"10.1515\/med-2025-1146","volume":"20","author":"F Zhang","year":"2025","unstructured":"Zhang F, Tang X, Zeng Z, Cao C, Yun C, Shen Y, Nie C, Xiong Y, Chulian M, Wu Y, Xu R (2025) Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy. Open Med (Wars) 20:20251146","journal-title":"Open Med (Wars)"},{"key":"2052_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40659-018-0157-8","volume":"51","author":"L Zhu","year":"2018","unstructured":"Zhu L, Han J, Yuan R, Xue L, Pang W (2018) Berberine ameliorates diabetic nephropathy by inhibiting TLR4\/NF-\u03baB pathway. Biol Res 51:9","journal-title":"Biol Res"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02052-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02052-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02052-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:02:00Z","timestamp":1792522920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02052-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02052-2","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper has been updated to clearly indicate the primary corresponding author and the co-corresponding author.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Publish declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"277"}}